The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
April 2nd 2024
The decision follows phase 3 trial results that demonstrated improved progression-free survival and confirmed the safety of Dato-DXd in patients with breast cancer.
No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens
December 8th 2023Study results indicate insignificant differences between PFS and OS in patients with HR[+]/HER2[-] breast cancer who received either palbociclib-letrozole or palbociclib-fulvestrant treatment.
Read More
Final Data From NATALEE Trial Show Benefit of Ribociclib Across Subgroups
December 8th 2023Gabriel N. Hortobagyi, MD, MACP, FASCO, a professor at the University of Texas MD Anderson Cancer Center, discussed the final data on invasive disease-free survival from the NATALEE trial of ribociclib in combination with a nonsteroid aromatase inhibitor (NSAI).
Watch
Expert: Pharmacists Play Key Role in Culturally Competent Care for Racially Diverse Patients
December 8th 2023Mara Hofherr, PharmD, a clinical oncology pharmacist at Washington University, highlights key findings of the KEYNOTE-522 trial in comparison of outcomes between Black and White patients with triple-negative breast cancer.
Watch
Expert: Evolution of Management of Breast Cancer has "Undergone Profound Changes"
December 7th 2023Gabriel Hortobagyi, MD, FACP, professor and chair emeritus of the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center discusses the changes in breast cancer management over the past decade.
Watch
Expert: Oncology Teams Need Standardized Questionnaires to Discuss Social Determinants With Patients
December 7th 2023Amelie G. Ramirez, DrPH, MPH, director of the Institute for Health Promotion Research at UT Health Science Center San Antonio, discussed the need for standardized questionnaires for clinicians to discuss social determinants of health with their oncology patients.
Watch